Physician

James Haywood Baker, M.D.

According to 2025 Medicare claims, James Baker, M.D. (NPI: 1497793731) practices cardiac electrophysiology in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. This provider's primary affiliated billing organization is SAINT THOMAS MEDICAL PARTNERS (NPI: 1437194669; TIN: 621529858) and primary practice location at 37205-2005. Baker is affiliated with the Ascension Care Management (ACO ID: A1061) and MID-TENNESSEE COMMUNITY ACO LLC (ACO ID: A5543), participating under the MSSP model.

Baker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,427 traditional Medicare patients, billed 7,853 HCPCS/CPT codes, and received $422,814 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,677 prescription claims across 984 beneficiaries totaling $1,887,001 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 41 records totaling $168,603. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $574,628 to $1,887,001. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,494	6,166	$433,643
2016	1,571	6,367	$448,574
2017	1,557	6,518	$452,177
2018	1,601	6,699	$494,683
2019	1,794	7,021	$474,424
2020	1,441	5,824	$414,282
2021	1,397	6,113	$462,513
2022	1,483	7,009	$425,511
2023	1,538	8,610	$429,990
2024	1,427	7,853	$422,814

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	646	5,224	$574,628
2016	694	5,919	$748,234
2017	716	5,790	$850,678
2018	738	5,154	$918,447
2019	778	4,809	$1,109,788
2020	798	4,947	$1,342,949
2021	798	4,668	$1,383,853
2022	848	4,473	$1,378,709
2023	954	5,062	$1,621,751
2024	984	5,677	$1,887,001

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	599	751	$80
93280	Programming of dual lead pacemaker system	256	321	$51
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	375	1,201	$19
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	553	1,773	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	554	713	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,306	65,036	$1,261,503
Xarelto	Rivaroxaban	301	16,322	$307,468
Multaq	Dronedarone Hcl	64	2,700	$66,870
Jardiance	Empagliflozin	59	2,250	$43,210
Entresto	Sacubitril/Valsartan	33	1,541	$34,440

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$716	Biosense Webster, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	28	$167,887	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Haywood Baker, M.D.?

Tedicare shows public-source Medicare data for James Haywood Baker, M.D. (NPI 1497793731), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Haywood Baker, M.D. have ACO affiliation data?

James Haywood Baker, M.D. is shown with ACO affiliation data for Ascension Care Management (MSSP, ACO ID A1061) and MID-TENNESSEE COMMUNITY ACO LLC (MSSP, ACO ID A5543).

What billing organization is linked to James Haywood Baker, M.D.?

James Haywood Baker, M.D. is linked to SAINT THOMAS MEDICAL PARTNERS (billing NPI 1437194669) in the available physician profile data.

Does James Haywood Baker, M.D. have Open Payments data?

James Haywood Baker, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.